Assessment on Antihypertensive Effect and Safety of Nifedipine Controlled-Release Tablet Administered at 80 mg/day in Practical Clinic

Author： Kobayashi Naohiko   Ishimitsu Toshihiko  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.34, Iss.3, 2012-05, pp. : 191-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Levetiracetam (3,000 mg/Day) as an Adjunctive Therapy in Chinese Patients with Refractory Partial Seizures

By  

European Neurology, Vol. 61, Iss. 4, 2009-01 ,pp. : 233-239

Karger

Access to resources Recommend Favorite

The Safety and Efficacy of Zileuton Controlled-Release Tablets as Adjunctive Therapy to Usual Care in the Treatment of Moderate Persistent Asthma: A 6-Month Randomized Controlled Study

By Wenzel Sally   Busse William   Calhoun William   Panettieri Reynold   Peters-Golden Mark   Dube Louise   Walton-Bowen Karen   Russell Heidy   Harris Judith  

Journal of Asthma, Vol. 44, Iss. 4, 2007-05 ,pp. : 305-310

Informa Healthcare

Access to resources Recommend Favorite

Low-dose (2.5 mg/day) finasteride treatment in hirsutism

By Bayram F.   Müderris I.   Güven M.   Özvelik B.   Keleştimur F.  

Gynecological Endocrinology, Vol. 17, Iss. 5, 2003-10 ,pp. : 419-422

Informa Healthcare

Access to resources Recommend Favorite

New alternative treatment in hirsutism: bicalutamide 25 mg/day

By Müderris İ. İ.   Bayram F.   Özçelik B.   Güven M.  

Gynecological Endocrinology, Vol. 16, Iss. 1, 2002-02 ,pp. : 63-66

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, 16 mg, Provides a Greater Antihypertensive Effect than Losartan, 50 mg, in Patients with Mild to Moderate Hypertension

By ANDERSSON O. K.   NELDAM S.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 55-55

Informa Healthcare

Access to resources Recommend Favorite